Piramal Enterprises (PEL.NS) Financial Analysis & Valuation | Quarter Chart
Piramal Enterprises (PEL.NS)
PEL.NSPrice: $12.06
Fair Value: 🔒
🔒score
Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, North America, Europe, Japan, and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company provides housing finance and other finan... more
Piramal Enterprises Limited operates in financial services and pharmaceuticals businesses in India, ... more
Description
Shares
| Market Cap | $2.73B | Exchange | NSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | IN | CEO | Yesh Nadkarni |
| IPO Date | 1996-01-02 | CAGR | 0.1% |
| Employees | 13,706 | Website | www.piramal.com/businesses/piramal-enterprises |
| Div. Yield | 53.75% | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | 53.75% |
PEL.NS chart loading...
Fundamentals
Technicals
| Enterprise Value | $258.61B | P/E Ratio | 44.24 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.08 | P/B Ratio | 0.06 |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $0.27 | EPS Growth 1Y | — |
| EPS Growth 3Y | -93.62% | EPS Growth 5Y | 6267.5% |
| Revenue Growth 1Y | 15.82% | Gross Margin | 0.82% |
| Operating Margin | 0.82% | Profit Margin | 0.06% |
| ROE | 0.02% | ROA | — |
| ROCE | — | Current Ratio | — |
| Quick Ratio | — | Cash Ratio | — |
| Debt/Equity | — | Interest Coverage | 1.38 |
| Altman Z Score | — | Piotroski Score | 4 |